The purpose of this research study is to see whether a tele-health intervention can improve health, functioning status, emotional status, quality of life, and patient satisfaction for patients with Congestive Heart Failure (CHF) and to examine the cost benefits of this intervention.
equal to or greater than 18 years old 1 + past CHF diagnosis in LSU database, with history of CHF diagnosis extending back for 12 months LSU primary care or chronic disease clinic patient for equal or greater than 6 months. On CHF medication for equal to or greater than 6 months Have had a past echocardiogram Mental competency to consent and participate (determined by clinical judgment and chart abstraction) Physically able to use in-home equipment (or presence of a household member who can assist the subject in equipment use) Currently-working conventional telephone line at primary residence Grounded electrical power supply at primary residence Anticipation of remaining in the LSU HCSD patient population for the next year Not on home oxygen therapy No planned surgery within the next six months Living at home (not institutionalized) No history of major organ transplant No diagnosis of metastatic or inoperable cancer Not under treatment for cancer Not under treatment for end-stage renal disease or end-stage liver disease 1 + emergency department visit or inpatient stay in past 12 months
Exclusion Criteria:
Are on home oxygen Have a planned surgery within the next 6 months Have a history of major organ transplant Have a diagnosis of metastatic or inoperable cancer Are under treatment for cancer Are under treatment for end-stage renal disease or end-stage liver disease Have HIV/AIDS Have a cognitive condition, such as Alzheimer's or dementia that would make it difficult for you to understand how to use the tele-health device.
